Catalyst Wire Dossier Catalyst Wire Dossier

MRKAd5 HIV-1 Gag Vaccine (V520)

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRKAd5 HIV-1 Gag Vaccine (V520), covering 2011-07-07 to 2011-07-07. Get the full timeline:

Most recent: Clinical Trial Update: MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED) [Phase 1]

See pricing